Another half a million shares less...
In February 2018, the Issuer's Board of Directors approved a share repurchase program, pursuant to which the Issuer is authorized to purchase up to $50 million of its Common Shares over a 12-month period. In connection with the Issuer's share repurchase program, as of June 18, 2018, the Company's total number of outstanding Common Shares decreased to 99,063,448 from the total number of 99,675,370 outstanding Common Shares as of June 11, 2018.
Longterm Investment, Biotechs & High Yield Dividend Stocks ... #board-11828